Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 606 participants.
Also called NCT01225094
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 606 participants
- Sponsor
- Registry
-
NCT01225094
-
- Other papers using this trial's data
- Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01225094. Randomized; quadruple masking; primary purpose prevention. Start 2011-11 (registry gives no type); primary completion 2014-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair
- Condition
- Acute Kidney Injury
- Condition
- Abdominal Aortic Aneurysm
- Intervention (Drug)
- curcumin
- Intervention (Other)
- placebo
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct01225094- Content hash
15b21e7f9d3478920d9442617973f7ad370c61b620fecc28e318f366d3ce6f48